Ultragenyx Pharmaceutical (RARE) Assets Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.21% |
| Dec 31, 2025 | 1.93% |
| Sep 30, 2025 | -22.62% |
| Jun 30, 2025 | -19.29% |
| Mar 31, 2025 | 0.37% |
| Dec 31, 2024 | 0.80% |
| Sep 30, 2024 | 24.25% |
| Jun 30, 2024 | 23.42% |
| Mar 31, 2024 | -5.52% |
| Dec 31, 2023 | -3.52% |
| Sep 30, 2023 | -23.50% |
| Jun 30, 2023 | -0.71% |
| Mar 31, 2023 | -0.05% |
| Dec 31, 2022 | 1.51% |
| Sep 30, 2022 | 9.00% |
| Jun 30, 2022 | -12.68% |
| Mar 31, 2022 | -13.38% |
| Dec 31, 2021 | -13.48% |
| Sep 30, 2021 | 17.06% |
| Mar 31, 2021 | 29.57% |
| Dec 31, 2020 | 54.96% |
| Sep 30, 2020 | 44.14% |
| Mar 31, 2020 | 22.36% |
| Dec 31, 2019 | 57.80% |
| Sep 30, 2019 | 15.00% |
| Jun 30, 2019 | 18.97% |
| Mar 31, 2019 | 23.30% |
| Dec 31, 2018 | 46.62% |
| Sep 30, 2018 | 75.88% |
| Jun 30, 2018 | 62.00% |
| Mar 31, 2018 | 49.75% |
| Dec 31, 2017 | -9.23% |
| Sep 30, 2017 | -15.55% |
| Jun 30, 2017 | 3.23% |
| Mar 31, 2017 | 4.13% |
| Dec 31, 2016 | -3.39% |
| Sep 30, 2016 | -14.44% |
| Jun 30, 2016 | 40.51% |
| Mar 31, 2016 | 47.31% |
| Dec 31, 2015 | 182.66% |
| Sep 30, 2015 | 185.46% |
| Jun 30, 2015 | 110.97% |
| Mar 31, 2015 | 106.04% |
| Dec 31, 2014 | 231.89% |